chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Projectile vomiting, fever, difficulty speaking and breathing (needed to take gulps of air in order to speak), difficulty taking in air, shaking, fever, unable to walk unassisted, loss of appetite and extreme nausea, unable to eat solid food/ keep food down, extreme headache and migraine symptoms, extreme fatigue, unable to work for approx. 5 days after the 2nd dose due to battling the various symptoms over the course of the adverse reaction
Almost instantaneous ovary pains, blood clots passing vaginally, abnormal vaginal bleeding for two weeks
Rash x 3-4 days began 3 days after receiving first dose Covid-19 vaccine. Presented to walk-in clinic after trying benadryl and coconut oil. Also with chills and headache. Patient prescribed Medrol Dosepak. Also advised to try OTC benadryl/claritin as needed, OTC hydrocortisone cream as needed.  Patient instructed to follow up with his PCP in 1 week and to go to the ER for shortness of breath, swallowing troubles, worsening rash, or worse symptoms.
WHEN MOM GOT HOME SHE REMOVED BANDAID FROM THE RIGHT LEG AND NOTICED REDNESS AT INJECTION SITE.  THE AREA WAS VERY TENDER, NOT WARM, REDNESS WAS THE SIZE OF A DIME.  ATE AND SLEPT NORMALLY. THE NEXT DAY MOM NOTICED THE REDDENED AREA WAS LARGER AND RAISED.  STILL VERY TENDER.  REDNESS LASTED UNTIL 7/24/06. THERE IS STILL SOME DISCOLORATION AT THE SITE. IT DOESN'T BOTHER HER AT ALL.
tested positive for Covid; tested positive for Covid; This is a spontaneous report from a Contactable Consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) in late Feb2021 as DOSE 1, SINGLE and in early Mar2021 as DOSE 2, SINGLE, both via an unspecified route of administration (Batch/Lot number was not reported) for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient just tested positive for covid last week in Jul2021. The patient underwent lab tests and procedures which included sars-cov-2 test: positive last week (Jul2021). The outcome of the events was unknown.   Information on the lot/batch number has been requested.
itching started after vaccine at night both arms- keep awake but used eczema cream and help- goes after by morning- continuing every night x for 4-5 hours  but goes away in the morning
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 20Jan2021 at 10:00 as dose 1, single (Lot number: el9261), in left arm, on 10Feb2021 at 12:00 as dose 2, single (Lot number: el9266), in left arm, on 15Aug2021 at 10:00 as dose 3 (booster), single (Lot number: fc3180), in left arm and on 17Mar2022 at 14:30 as dose 4 (booster), single (Lot number: fk9899) at the age of 72 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: penicillin" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative; Positive; Negative. Therapeutic measures were taken as a result of drug ineffective, covid-19.
A week after vaccination, swelling of arm turn the skin red and itches.  It looked like a rash. Rash expanded in size and itchiness is more intense. It comes and goes. Went to see doctor on January 27 and have been diagnosed with cellulitis. Currently on Keflex for treatment.
Patient was told by MD to get PREVNAR 13 since she had PNEUMOVAX quite a few years ago. We ran it thru I did administer it, not understanding the flow chart that she should wait until age 65. I was not thorough in my research before giving it. No known adverse rxn.
Right arm swollen. Pain in joints and muscle tissue. Headache and nausea. Inability to work or be productive for 5 days.
Immediate symptoms after the vaccine were:  I got not only very tired and felt miserable. I had to be off of work for the day. I can't remember exactly what the symptoms were because I felt unbelievably miserable. I didn't want to eat or do anything. It lasted for a day. In July, I noticed cold symptoms and I thought I had a bad sinus infection. Nose running, congestion and then I began coughing. I had one episode when I was coughing when I couldn't breathe for 10 seconds. I got through that episode and then I went to Urgent Care. They gave me steroids - for about five days and I quarantined. That helped with my symptoms. I started feeling better within a couple of days but I quarantined until August 2 when I went back to work.
pt recv vax last wednesday & wednesday was fine, Thursday was fine but Friday morning body aches, bad h/a, legs hurt, just flu sx;
pt recvd vax & exp pain;2 days p/vax pt devel throbbing sensation of pain to lt shoulder area,& the usual soreness & stiffness;pt exp limited mobility;pt seen by several MD's w/no relief;pt later exp joint pain/arthritis;dx poss bursitis
menstruation cycle delay; This case was reported by a consumer via interactive digital media and described the occurrence of menstruation delayed in a 13-year-old female patient who received HPV 16-18 (HPV vaccine) for prophylaxis.   On 3rd October 2021, the patient received the 1st dose of HPV vaccine. On an unknown date, less than 3 weeks after receiving HPV vaccine, the patient experienced menstruation delayed. On an unknown date, the outcome of the menstruation delayed was unknown.   It was unknown if the reporter considered the menstruation delayed to be related to HPV vaccine.  Additional details were provided as follows: This case was reported by patient's parent. The patient was vaccinated with 1st dose of Human Papillomavirus vaccine first dose on 3rd October 2021and now her menstruation cycle delayed 15 days. The last menstruation cycle was on 5th September 2021.  The patient's parent had a doubt that was there any relationship between HPV vaccination and menstruation delayed and requested to clear his/her doubt.
Immediately after administration of Pneumovax 23, patient stated she felt lightheaded and lowered head to knees. She then slumped briefly and slid to ground, I caught her shoulder to ease her to the floor.  She did not seem to lose consciousness fully and stated she had the same event previously while donating plasma.  She stated it usually passed after 5 minutes.  She refused an ammonia ampule and took a glass of water.  After 10 minutes of observation, she left the pharmacy without a word.
Information has been received from a consumer concerning a child in her family who was vaccinated on an unspecified date with a dose of MMR II. Subsequently the child developed autism. Unspecified medical attention was sought. Upon internal review, autism was determined to be an other important medical event (OMIC). Additional info has been requested.
Headache, Fever & NauseaVomiting Narrative:  chills, lymphadenitis left axillary, nodes still tender
Shots given on 11/12/2004, patient on her way home from office and emesis with rash, hive-like appearance occurred. No respiratory distress or cough noticed. Mom gave Benadryl po per age/wt/appropriate dose. Called back 1/2 hour later and as doing much better.
the patient said she had yellow fluid coming out of her hand; This is a spontaneous report from a contactable pharmacist. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number was not provided), via an unspecified route of administration, on an unspecified date as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was stated that, with the first dose of the vaccine, on an unspecified date, the patient had yellow fluid coming out of her hand. The outcome of the event was unknown at the time of report.  Information about lot/batch number is requested.
2nd case of shingles. Pt has received Shingrix vaccines/ suspected vaccination failure; shingles; This case was reported by a other health professional via sales rep and described the occurrence of suspected vaccination failure in a 91-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis, mepolizumab (Nucala) solution for injection for product used for unknown indication and prednisone for product used for unknown indication.   The patient's past medical history included shingles (had 1st outbreak of shingles, refer case US2021252020).   On an unknown date, the patient received Shingrix, the 1st dose of Shingrix, Nucala 100 mg at an unknown frequency and prednisone at an unknown dose and frequency. On an unknown date, unknown after receiving Shingrix and Shingrix and not applicable after starting Nucala, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. The action taken with Nucala was unknown. The action taken with prednisone was unknown. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix. It was unknown if the reporter considered the shingles to be related to Nucala.  Additional details were provided as follows: The age at vaccination was unknown. The patient received Shingrix vaccines (timeline of Shingrix vaccine was unknown) and developed 2nd case of shingles while on Nucala 100 mg and Prednisone. No updated status and date of onset was available for the patient at the time of reporting. The patient's history part and demographics were unknown. It was unknown if the reporter considered the shingles to be related to Prednisone. The reporter consented to follow up. This case was considered as suspected vaccination failure as details regarding the laboratory test confirming shingles and time to onset for shingles were unknown at the time of reporting.  Note: In source document there was discrepancy for outcome details but as per description patient's status was unknown, hence conservative outcome was considered as unknown. Clarification had been raised.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021252020:same reporter
62 yo female who received influenza immunization for the 1st time in Oct. or Nov., 2007 and since then has suffered with profound fatigue, somnolence and scalp lesions. Dizziness and giddiness, rash, oth nonspecific skin eruption.
Patient had flu shot at her obstetrician, patient is pregnant. That evening she complained of a severe headache, 10/10 on a scale of 1-10, a fever of 102 degrees. Came to the health clinic next day, complaining of occipital head that was 6/10 before Tylenol. She was advised to see doctor or go to the ER.
Fever; Headaches; side effects; This case was reported by a physician via other manufacturer and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced fever, headache and adverse event. On an unknown date, the outcome of the fever, headache and adverse event were unknown.   It was unknown if the reporter considered the fever, headache and adverse event to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication.  The patient received Shingrix and had side effects potentially fever and headache. The reporter consent to follow up.
Syncope experienced immediately following second shot (Havrix). Pt experienced loss of consciousness for approx. 30 seconds. Upon wakening patient experienced N/V for up to 10 minutes. All symptoms resolved with in 15 minutes. Blood pressure was 112/80.
Headache, fever, nausea, vomiting, diarrhea, red arm site, runny nose, fatigue, body aches
Had Seizure (Grand Mal), then developed fever. Taken to RE following seizure lasted 3", temp 102.2, child Afebrile when vaccines given.
About 1 hour after receiving flu shot, patient's throat started swelling.  She felt sick.  About 2 hour she reported itchy throat, cough, but no shortness of breath.  Her face was itchy, eyes swelling and bloodshot.  She admitted herself to the Emergency Department, which is received treatment for about 3 hours.  She received treatment of PREDNISONE which help reduce symptoms signifigntly. Good recovery.  MD believes she may be allergic to preservatives.
Shot at 2pm. Took Motrin at 8pm. Woke up at 11pm fever 102. Shaking and hallucinating. Head in a vice. 10/10. Fatigue started 12/27  and lasted until 1pm
She had the Moderna COVID-19 Vaccine and Pfizer Booster COVID-19 Vaccine; right after the Booster she got the blood clot in her lungs and on her leg; right after the Booster she got the blood clot in her lungs and on her leg; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (Private).  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Moderna covid-19 vaccine (Dose number: Unknown), for COVID-19 immunization. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown", described as "She had the Moderna COVID-19 Vaccine and Pfizer Booster COVID-19 Vaccine"; PULMONARY THROMBOSIS (medically significant), THROMBOSIS (medically significant), outcome "unknown" and all described as "right after the Booster she got the blood clot in her lungs and on her leg". The caller (reporter) is calling on behalf of her mom (consumer) actually. She said that her mother got the Pfizer Booster COVID-19 Vaccine and as a result her mother had a lungs blood clot and also on the leg." When paraphrased the concern, reporter stated, "She had the Moderna COVID-19 Vaccine and Pfizer Booster COVID-19 Vaccine and right after the Booster she got the blood clot in her lungs and on her leg. Yes she got the Moderna COVID-19 Vaccine and the Pfizer Booster COVID-19 Vaccine."  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
The evening after getting shot, developed headache and sore arm. Progressing to now the symptoms include: brain fog, seeing fuzz or spots in vision, tremors, numbness & tingling in extremities, feeling of loss of control of limbs, dizziness. Sore arm has never gotten better, other symptoms continue to become progressively worse.
7:20 AM Fever 102.5, nausea, chills, 1:50 PM Fever reduced to 100.8 no chills, no medications taken, bed rest
On 11/15/2021- left eye mild pain, every day it got progressively worse. On Friday,  night the pain was so bad, so I called the eye doctor and asked if they could get me in because my eye was in a lot of pain. On 11/20/2021 -The doctor does not know what caused the pain, she saw these yellow bumps and said that is what caused me the pain in my left eye and she prescribed me eye medication for 10 days, 1 drop in my left eye, 4 times a day for 10 days- prednisolone ophthalmic suspension 1 % . I asked he doctor if she thinks something got in my eye that caused the yellow bumps. I don't suffer from allergies. So I don't  know what caused it and the doctor could not tell me what caused it. I have recovered from the pain in my left eye and I have not had any recurrence of eye pain.
Erythema and pruritus on upper arms B/L at site of vaccination. At 2015 rapid response team called as patient c/o increased breathing difficulty. Pt given IV BENADRYL and ZOFRAN.
This spontaneous report as received from a nurse refers to a 17 year old patient of unknown gender. No information regarding the patient's pertinent medical history and concomitant medications was reported. On 16-APR-2015, the patient was vaccinated with an "adult dose" of VAQTA, 1 ml (route of administration, lot # and expiration date were not provided). As of 02-JUN-2015, no adverse effect was reported. Additional information has been requested.
SORE ARM; BRUISE AT INJECTION SITE; BODY ACHES; SLIGHT HEADACHE; TIREDNESS; This spontaneous report received from a patient concerned a 52 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included tear in right shoulder.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, and expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 07:50 for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021, the subject experienced body aches. On 06-APR-2021, the subject experienced slight headache. On 06-APR-2021, the subject experienced tiredness. On 09-APR-2021, the subject experienced bruise at injection site. On an unspecified date, the subject experienced sore arm. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, slight headache, and tiredness on 07-APR-2021, and had not recovered from sore arm, and bruise at injection site. This report was non-serious.
Severe nausea, constant burping, severe-er than normal diarrhea, vomiting several times, chills, restlessness,
hypovolemic shock secondary to nausea and vomiting  Had eaten frozen fish cooked in an air fryer two hours previously--had previously cooked the same fish by the same method without ill effect.  No ill contacts.  Not social gatherings.  Lives by herself and is afraid to be near anyone  Incidental finding of pulmonary embolus on evaluation--see below.  No prior h/o VTE
itching all over his body; stomach felt upset; can't walk around; This is a spontaneous report from a Regulatory Authority. contactable consumer. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via an unspecified route of administration on 28Jan2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced itching all over his body after 10 days and advised to take Benadryl and until 2nd shot (18Feb2021). The patient was still taking Benadryl and when his stomach felt upset, bad and can't walk around and even can't sit so decided to stop taking that medicine but the itching didn't stop. The patient mentioned after he stopped taking the Benadryl his arms, behind ears, shoulder and his back was itching and it doesn't stay on one spot. Therapeutic measures were taken as a result of itching all over his body. The outcome of the event itching all over his body was not recovered. The outcome of the events stomach felt upset and can't walk around was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Redness, soreness, swelling, and warmth at injection site accompanied by headache 7/10. Administered Acetaminophen 1,000 mg and Ibuprofen 600 mg PO. Applied Hydrocortisone ointment topically to direct area of concern. Covered with Ice and secured with COBAN.
196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent).    Concomitant medication was not provided. 196 patients received 0.25mL of Moderna COVID-19 Vaccine, Bivalent. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live follow up information received.
Havrix was exposed to 15.6 F and administered to a patient/inadvertently administered the havrix vaccine following a temperature excursion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 69-year-old male patient who received HAV (Havrix 1440) (batch number 3J9G4, expiry date 30-AUG-2025) for prophylaxis.   On 26-JUN-2023, the patient received Havrix 1440 (left deltoid). On an unknown date, an unknown time after receiving Havrix 1440, the patient experienced incorrect storage of drug (Verbatim: Havrix was exposed to 15.6 F and administered to a patient/inadvertently administered the havrix vaccine following a temperature excursion). The outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 26-Jun-2023 The reporter believed that health care professional (HCP) stated that the vaccine expired on August30, 2025 but batch number identifier pulled up as August 31, 2025 so that was what was coded. The vaccine coordinator stated that Havrix was 15.6 degree Fahrenheit and administered to the patient which led to incorrect storage of drug. The reporter consented to follow up via email. The case is linked with US2023088674, by same reporter.; Sender's Comments:  US-GSK-US2023088674:Same reporter